NCT00891241View on ClinicalTrials.gov

A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Heart Failure
Interventions
DRUG

LMI 1195-101

Single dose, bolus IV injection of LMI 1195

Trial Locations (2)

06102

Hartford Hospital, Hartford

06250

Yale University Medical Center, New Haven

Sponsors
All Listed Sponsors
lead

Lantheus Medical Imaging

INDUSTRY